ArticleInternational cancer conference journal2021

A long-term survivor of metastatic neuroendocrine prostate cancer treated with multimodal therapy: genetic consideration from next-generation sequencing.

Hiroshi Hongo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.